Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MHFH04-4 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- Fetal Hemoglobin Monoclonal Antibody (HBF-1), PE
- Antibody type
- Monoclonal
- Antigen
- Other
- Description
- R-phycoerythrin (PE) is a stable and highly soluble phycobiliprotein which provides maximal absorbance and fluorescence without susceptibility to internal or external fluorescence quenching, thus providing an exceptional quantum yields and molar extinction coefficients.
- Conjugate
- Yellow dye
- Antibody clone number
- HBF-1
Submitted references In Vitro and In Vivo Studies for the Investigation of γ-Globin Gene Induction by Adhatoda vasica: A Pre-Clinical Study of HbF Inducers for β-Thalassemia.
Metformin induces FOXO3-dependent fetal hemoglobin production in human primary erythroid cells.
Inhibition of G9a methyltransferase stimulates fetal hemoglobin production by facilitating LCR/γ-globin looping.
Quantification of feto-maternal haemorrhage (FMH) by flow cytometry: anti-fetal haemoglobin labelling potentially underestimates massive FMH in comparison to labelling with anti-D.
Iftikhar F, Rahman S, Khan MBN, Khan K, Khan MN, Uddin R, Musharraf SG
Frontiers in pharmacology 2022;13:797853
Frontiers in pharmacology 2022;13:797853
Metformin induces FOXO3-dependent fetal hemoglobin production in human primary erythroid cells.
Zhang Y, Paikari A, Sumazin P, Ginter Summarell CC, Crosby JR, Boerwinkle E, Weiss MJ, Sheehan VA
Blood 2018 Jul 19;132(3):321-333
Blood 2018 Jul 19;132(3):321-333
Inhibition of G9a methyltransferase stimulates fetal hemoglobin production by facilitating LCR/γ-globin looping.
Krivega I, Byrnes C, de Vasconcellos JF, Lee YT, Kaushal M, Dean A, Miller JL
Blood 2015 Jul 30;126(5):665-72
Blood 2015 Jul 30;126(5):665-72
Quantification of feto-maternal haemorrhage (FMH) by flow cytometry: anti-fetal haemoglobin labelling potentially underestimates massive FMH in comparison to labelling with anti-D.
Kennedy GA, Shaw R, Just S, Bryson G, Battistutta F, Rowell J, Williams B
Transfusion medicine (Oxford, England) 2003 Feb;13(1):25-33
Transfusion medicine (Oxford, England) 2003 Feb;13(1):25-33
No comments: Submit comment
No validations: Submit validation data